Nurse Practitioner, Primary Care · Henderson, NV
NPI
1821620469
Since 2020
Specialty
Nurse Practitioner, Primary Care
Code 363LP2300X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2653 Bad Rock Cir
Henderson, NV, 89052
Phone (702) 445-9723
Groups this clinician bills Medicare through
Medicare paid, 2024
$104K
1,580 services
Medicare patients, 2024
154
Average age 77
Drug cost, 2024
$36K
193 prescriptions
Company payments, 2025
$162
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Camatchy Radjassegarane was code 99233 (hospital e&m - subsequent), 653 times for 100 patients. In total Camatchy Radjassegarane billed 1,580 services in 10 codes, and Medicare paid $104K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 653 | 100 | $76.73 | $50K |
| 99232 Hospital E&M - Subsequent | Facility | 627 | 87 | $51.40 | $32K |
| 99308 SNF E&M | Facility | 95 | 13 | $47.02 | $4,467 |
| 99223 Hospital E&M - Initial | Facility | 87 | 86 | $113.01 | $9,832 |
| 99309 SNF E&M | Facility | 58 | 14 | $69.69 | $4,042 |
| 99213 Office E&M - Established | Office | 49 | 30 | $55.89 | $2,738 |
By year: 2022 $118K for 1,861 services; 2023 $44K for 677 services; 2024 $104K for 1,580 services.
Medicare prescription drug claims, 2024
In 2024, the drug Camatchy Radjassegarane prescribed most often to Medicare patients was Zosyn (Piperacillin-Tazo-Dextrose,iso), with 28 prescriptions and refills. In total Camatchy Radjassegarane wrote 193 Medicare prescriptions that cost $36K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Zosyn Piperacillin-Tazo-Dextrose,iso | 28 | 28 | Under 11 | $6,324 |
| Daptomycin Generic | 20 | 20 | Under 11 | $19K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 18 | 18 | 15 | $220 |
| Fluconazole Generic | 18 | 18 | 17 | $233 |
| Cefepime Hcl Generic | 12 | 12 | Under 11 | $1,256 |
| Nystatin-Triamcinolone Nystatin/Triamcinolone Acet | 12 | 12 | Under 11 | $262 |
Brand drugs: 61 claims; generic drugs: 132 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Camatchy Radjassegarane $162 ($162 in general payments such as food, travel and fees) from 2 companies. The largest payer was Aimmune Therapeutics, Inc. with $125.
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Abbvie Inc. ABBV | 2 | $36.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.